Influence of obstructive sleep apnea on ischemia-modified albumin levels and carotid intima-media thickness

Journal of Investigative Medicine

Volumn 64, Issue 5, 2016, Pages 1035-1041

  Karamanli, Harun ^a   Kiyici, Aysel ^b   Arik, Bilal ^b   Efe, Duran ^b   Akgedik, Recep ^c  

^a Chest Disease and Chest Surgery Hospital of Ankara   (Turkey)

^b MEVLANA UNIVERSITY   (Turkey)

^c ORDU UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ISCHEMIA MODIFIED ALBUMIN; BIOLOGICAL MARKER; HUMAN SERUM ALBUMIN; ISCHEMIA-MODIFIED ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; APNEA HYPOPNEA INDEX; ARTERIAL OXYGEN SATURATION; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXIDATIVE STRESS; OXYGEN DESATURATION; POLYSOMNOGRAPHY; PROSPECTIVE STUDY; SLEEP DISORDERED BREATHING; BLOOD; CASE CONTROL STUDY; DEMOGRAPHY; METABOLISM; PATHOLOGY; STATISTICAL MODEL;

BIOMARKERS; BODY MASS INDEX; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; SERUM ALBUMIN, HUMAN; SLEEP APNEA, OBSTRUCTIVE;

EID: 84979997716     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.1136/jim-2016-000063     Document Type: Article

References (47)

1. Fava C, Montagnana M, Favaloro EJ, et al. Obstructive sleep apnea syndrome and cardiovascular diseases. Semin Thromb Hemost 2011;37:280-97.
2. Quan SF, Gersh BJ, National Center on Sleep Disorders Research; National Heart, Lung, and Blood Institute. Cardiovascular consequences of sleep-disordered breathing: past, present and future: report of a workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute. Circulation 2004;109:951-7.
3. Suzuki YJ, Jain V, Park AM, et al. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med 2006;40:1683-92.
4. Sinha MK, Gaze DC, Tippins JR, et al. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation 2003;107:2403-5.
5. Bhagavan NV, Lai EM, Rios PA, et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 2003;49:581-5.
6. Turedi S, Gunduz A, Mentese A, et al. Value of ischemia-modified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med 2007;25: 770-3.
7. Roy D, Quiles J, Gaze DC, et al. Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 2006;92:113-14.
8. Senes M, Kazan N, Coskun O, et al. Oxidative and nitrosative stress in acute ischaemic stroke. Ann Clin Biochem 2007;44(Pt 1):43-7.
9. Aminbakhsh A, Mancini GB. Carotid intima-media thickness measurements: what defines an abnormality? A systematic review. Clin Invest Med 1999;22:149-57.
10. Silvestrini M, Rizzato B, Placidi F, et al. Carotid artery wall thickness in patients with obstructive sleep apnea syndrome. Stroke 2002;33: 1782-5.
11. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000;19:311-15.
12. Lippi G, Montagnana M, Salvagno GL, et al. Standardization of ischemia-modified albumin testing: adjustment for serum albumin. Clin Chem Lab Med 2007;45:261-2.
13. Pignoli P, Tremoli E, Poli A, et al. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74:1399-406.
14. Duarte MM, Rocha JB, Moresco RN, et al. Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia. Clin Biochem 2009;42:666-71.
15. Ciccone MM, Scicchitano P, Zito A, et al. Correlation between inflammatory markers of atherosclerosis and carotid intima-media thickness in Obstructive Sleep Apnea. Molecules 2014;19:1651-62.
16. Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 2000;320:479-82.
17. Ciccone MM, Scicchitano P, Mitacchione G, et al. Is there a correlation between OSAS duration/severity and carotid intima-media thickness? Respir Med 2012;106:740-6.
18. Burke GL, Evans GW, Riley WA, et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke 1995;26:386-91.
19. Eren M, Gorgulu S, Uslu N, et al. Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both. Heart. 2004;90:37-43.
20. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22.
21. Garvey JF, Taylor CT, McNicholas WT. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 2009;33:1195-205.
22. Damiani MF, Carratù P, Quaranta VN, et al. Influence of obstructive sleep apnea on endothelial function in obese patients. Chest 2012;141:1639; author reply 1640.
23. Atkeson A, Yeh SY, Malhotra A, et al. Endothelial function in obstructive sleep apnea. Prog Cardiovasc Dis 2009;51:351-62.
24. Glass CK, Witztum JL. Atherosclerosis. the road ahead. Cell 2001;104:503-16.
25. Lavie L. Obstructive sleep apnoea syndrome-an oxidative stress disorder. Sleep Med Rev 2003;7:35-51.
26. Ciftci TU, Kokturk O, Bukan N, et al. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 2004;28:87-91.
27. Dean RT, Wilcox I. Possible atherogenic effects of hypoxia during obstructive sleep apnea. Sleep 1993;16(8 Suppl):S15-21; discussion S21-2; discussion S-2.
28. Minoguchi K, Yokoe T, Tazaki T, et al. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 2005;172:625-30.
29. Suzuki T, Nakano H, Maekawa J, et al. Obstructive sleep apnea and carotid-artery intima-media thickness. Sleep 2004;27:129-33.
30. Roche M, Rondeau P, Singh NR, et al. The antioxidant properties of serum albumin. FEBS Lett 2008;582:1783-7.
31. Ahn JH, Choi SC, Lee WG, et al. The usefulness of albumin-adjusted ischemia-modified albumin index as early detecting marker for ischemic stroke. Neurol Sci 2011;32:133-8.
32. Uygun M, Yilmaz S, Pekdemir M, et al. The diagnostic value of ischemia-modified albumin in a rat model of acute mesenteric ischemia. Acad Emerg Med 2011;18:355-9.
33. Hogg K, Hinchliffe E, Halsam S, et al. Is ischaemia-modified albumin a test for venous thromboembolism? Emerg Med J 2012;29:455-9.
34. Turedi S, Gunduz A, Mentese A, et al. The value of ischemia-modified albumin compared with d-dimer in the diagnosis of pulmonary embolism. Respir Res 2008;9:49.
35. Turedi S, Cinar O, Kaldirim U, et al. Ischemia-modified albumin levels in carbon monoxide poisoning. Am J Emerg Med 2011;29:675-81.
36. Roy D, Quiles J, Sharma R, et al. Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem 2004;50:1656-60.
37. Piwowar A, Knapik-Kordecka M, Warwas M. Ischemia-modified albumin level in type 2 diabetes mellitus-Preliminary report. Dis Markers 2008;24:311-17.
38. Kiyici A, Mehmetoglu I, Karaoglan H, et al. Ischemia-modified albumin levels in patients with end-stage renal disease patients on hemodialysis: does albumin analysis method affect albumin-adjusted ischemia-modified albumin levels? J Clin Lab Anal 2010;24:273-7.
39. Oncel M, Kiyici A, Onen S. Evaluation of the relationship between ischemia-modified albumin levels and thyroid hormone levels. J Clin Lab Anal 2015;29:427-31.
40. Dadaci Z, Oncel M, Oncel Acir N, et al. Oxidative stress parameters and serum magnesium levels in patients with seasonal allergic conjunctivitis. Cutan Ocul Toxicol 2015;10:1-5.
41. Yang LX, Ma SG, Liu H, et al. Influence of obstructive sleep apnea on serum butyrylcholinesterase activity and ischemia-modified albumin levels. Clinics (Sao Paulo) 2013;68:968-73.
42. Ozben S, Huseyinoglu N, Hanikoglu F, et al. Advanced oxidation protein products and ischaemia-modified albumin in obstructive sleep apnea. Eur J Clin Invest 2014;44:1045-52.
43. Morrison KM, Dyal L, Conner W, et al. Cardiovascular risk factors and non-invasive assessment of subclinical atherosclerosis in youth. Atherosclerosis 2010;208:501-5.
44. Wattanakit K, Boland L, Punjabi NM, et al. Relation of sleep-disordered breathing to carotid plaque and intima-media thickness. Atherosclerosis 2008;197:125-31.
45. Altin R, Ozdemir H, Mahmutyazicioglu K, et al. Evaluation of carotid artery wall thickness with high-resolution sonography in obstructive sleep apnea syndrome. J Clin Ultrasound 2005;33:80-6.
46. Schulz R, Seeger W, Fegbeutel C, et al. Changes in extracranial arteries in obstructive sleep apnoea. Eur Respir J 2005;25:69-74.
47. Baguet JP, Hammer L, Levy P, et al. The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 2005;128:3407-12.